Although the cause of multiple myeloma is not known, research shows that genetic changes in the DNA of a single plasma cell ...

In spite of recent advances in the management of multiple myeloma, cure has been elusive, with efforts to improve long-term ...

Regeneron Pharmaceuticals has received a positive opinion from the European Medicines Agency’s human medicines committee for ...

An elderly patient who was initially suspected of having antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) was instead diagnosed with multiple myeloma, according to a case report ...

Multiple myeloma (MM) is a blood cancer that affects plasma cells in bone marrow. It’s a particularly insidious form of ...

Alfred L. Garfall, MD, discusses the phase 2 BMT CTN 1902 trial of idecabtagene vicleucel in patients with multiple myeloma.

Study reveals multiple high-risk genetic changes predict worse multiple myeloma outcomes across all treatments.

Welcome Home of Chattanooga is celebrating 10 years of service to the Tennessee Valley. To kick off their 10 year anniversary ...

Patients with RA who have used b/tsDMARDs demonstrated similar risks for multiple myeloma when compared with those taking only csDMARDs.

Discover how ctDNA revolutionizes multiple myeloma monitoring, tracking disease progression, and improving personalized ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Multiple myeloma is a rare blood cancer of the plasma cells in bone marrow -- the soft, spongy interior of bone where ...

Follow along on our guide to Multiple Myeloma, a cancer of the bone marrow's infection-fighting plasma cells. As cancerous ...